SEARCH
YOUR SEARCH FOR Text 261 RESULTS
21 of Total
Compliance & Transparency | Incyte.com
Compliance & Transparency We aim to make a difference by conducting business with the highest integrity, making information available as needed
22 of Total
State Disclosures | Incyte.com
State Disclosures Colorado Disclosure Act Colo. Rev. Stat. § 12-280-308 requires pharmaceutical manufacturers, when engaging in prescription drug
23 of Total
Suppliers | Incyte.com
Supplier Portal Incyte partners with skilled, valued suppliers across the globe who share our values, to build strong, lasting relationships that
24 of Total
Collaboration | Partners in Science | Incyte.com
Joining Forces to Improve the Lives of Patients We are pushing the bounds of what is possible in developing treatments for serious diseases with
25 of Total
Dermatology Research: Immune-Mediated Dermatologic Conditions | Incyte.Com
Developing the Next Generation of Dermatology Treatments Incyte’s science-first approach and heritage in immunology has formed the foundation of our
26 of Total
Drug Development & Scientific Innovation in Oncology and Inflammation & Autoimmunity | Incyte.com
How We Solve On . Our strength lies in the collective experience, passion and perseverance of our team. From our inception, we have relentlessly
27 of Total
Oncology Research | Targeted & Immunotherapy For Cancer | Incyte.com
Transforming the Treatment Landscape in Oncology At Incyte, we are harnessing breakthrough science to deliver medicines that may offer patients new
28 of Total
Portfolio: MPNs & GVHD, Hematology/Oncology, Dermatology & Inflammation & Autoimmunity | Incyte.com
Explore Our Science We have a breadth of clinical programs within our portfolio across Myeloproliferative Neoplasms (MPNs) and Graft-Versus-Host
29 of Total
COVID-19 | Incyte.com
Incyte COVID-19 Response Incyte takes public health very seriously, and we are closely monitoring the COVID-19 pandemic. Our primary focus is on
30 of Total
Global Biopharmaceutical Company | Incyte.com
Incyte is a Biopharmaceutical Company on a Mission to Solve On . 2500 Employees with operations in North America, Europe and Asia 1000 Research and